Ionis Prices Alexander Disease Drug at 285000 Dollars
Ionis Pharmaceuticals has priced its newly approved rare disease treatment Zanvastro at $285000 per dose. The therapy is the first FDA-cleared option for Alexander disease and will launch in the U.S. soon.
Xurve View
Insights:
Xurve View